Peter Chin-Hong

MD

Infectious disease physician
Education and social justice warrior, beach lover

About me

Dr. Peter Chin-Hong specializes in treating infectious diseases. He has a focus on infections that develop in immunosuppressed patients, such as recipients of organ and stem cell transplants, particularly HIV-positive recipients of organ transplants.

In research, Chin-Hong studies human papillomavirus, Chagas disease, and viral and fungal infections in patients with suppressed immune systems. His findings have been published in numerous journals and books.

Chin-Hong earned his undergraduate and medical degrees from Brown University. He completed a residency in internal medicine and a fellowship in infectious diseases at UCSF.

In addition to patient care, Chin-Hong is associate director of the UCSF Clinical and Translational Science Institute's predoctoral research fellowship programs. He has received numerous prestigious teaching awards from UCSF.

Chin-Hong is a member of the Infectious Diseases Society of America, American Society for Microbiology and American Society of Transplantation.

  • Education

    Warren Alpert Medical School of Brown University, 1997

  • Residencies

    UCSF, Internal Medicine, 2000

  • Fellowships

    UCSF, Infectious Diseases, 2002

  • Academic Title

    Professor

Healing is not just medicine. Heart, mind and soul are key ingredients.

Conditions I specialize in

  • Infectious diseases

Clinics I work with

View map

Infectious Diseases Clinic

400 Parnassus Ave., Second Floor
San Francisco, CA 94143

(415) 353-2626
M-F, 8 a.m. - noon, 1 p.m. - 5 p.m.

Selected research

Decorative Caduceus

Pneumonia in the ImmunoCompromised - Use of the Karius Test for the Detection of Undiagnosed Pa...

Percent of patients with ≥1 pathogen identified by the Karius Test collected at enrollment that is adjudicated as a probable cause of the subject's index pneumonia event with no pathogen identified as a probable cause of the subje...

Recruiting

Contact me

Providers on my team

Share